Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Quick Stats
Jun 23, 202665.8
AI Score
BUY1.13
Volume Ratio
Aug 05, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
PTGX Stock Summary
Last updated Jun 23, 2026
PTGX is currently trading at $118.96, positioned above its 200-day moving average of $88.09, indicating a long-term uptrend. The stock has a 52-week range of $49.38 to $119.85.
Technical Analysis: The 50-day moving average stands at $102.92, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 69.131, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.03, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PTGX at 65.8/100 with a BUY recommendation.
PTGX (Protagonist Therapeutics, Inc) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 69.131 |
| CMF (20) | -0.03 |
| ROC (10) | 20.58 |
| ADX (14) | 33.43 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 3.908 |
| AROONOSC (14) | 100.0 |
| WILLAMS %R (14) | -6.127 |
| MFI (14) | 82.28 |
PTGX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PTGX Price vs Max Options Open Interest
PTGX Max Change In Options Open Interest
PTGX Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PTGX Daily Out of Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PTGX Daily In the Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PTGX Most Active Options by Volume(near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Protagonist Therapeutics, Inc is above both 50 Day and 200 Day SMA which is considered Bullish.
PTGX Moving Averages Analysis
Protagonist Therapeutics, Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 23, 2026
Protagonist Therapeutics, Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 23, 2026
PTGX (Protagonist Therapeutics, Inc) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 111.26 |
| 20 | 104.83 |
| 30 | 103.76 |
| 50 | 102.92 |
| 100 | 97.74 |
| 200 | 88.09 |
PTGX Fundamental Analysis
| P/E (Forward) | 24.3309 |
| P/E (Trailing) | -- |
| Market Cap ($) | 7.6 billion |
| Earnings/Share ($) | -1.81 |
| Net Proft Margin (%) | -1.5488 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 4.1733 |
| EPS Estimate Next Year ($) | -0.6847 |
| WallStreet Target Price ($) | 118.6923 |
| Most Recent Quarter |